Skip to main content
. 2020 May 29;28(3):249–271. doi: 10.3727/096504019X15766663541105

Table 3.

Comparison of CR in Subgroups Divided by Biochemical Indexes

Parameters N Not CR CR p Value
Blood routine
 WBC 0.965
  Abnormal 96 77 (80.2) 19 (19.8)
  Normal 270 216 (80.0) 54 (20.0)
 RBC 0.331
  Abnormal 138 114 (82.6) 24 (17.4)
  Normal 227 178 (78.4) 49 (21.6)
 ANC 0.070
  Abnormal 101 87 (86.1) 14 (13.9)
  Normal 264 205 (77.7) 59 (22.3)
 Hb 0.186
  Abnormal 155 129 (83.2) 26 (16.8)
  Normal 210 163 (77.6) 47 (22.4)
 PLT 0.593
  Abnormal 145 114 (78.6) 31 (21.4)
  Normal 220 178 (80.9) 42 (19.1)
Liver function
 ALB 0.022
  Abnormal 143 123 (86.0) 20 (14.0)
  Normal 223 170 (76.2) 53 (23.8)
 TP 0.330
  Abnormal 94 72 (76.6) 22 (23.4)
  Normal 272 221 (81.3) 51 (18.8)
 TBIL 0.338
  Abnormal 94 72 (76.6) 22 (23.4)
  Normal 271 220 (81.2) 51 (18.8)
 TBA 0.753
  Abnormal 126 99 (78.6) 27 (21.4)
  Normal 215 172 (80.0) 43 (20.0)
 ALT 0.762
  Abnormal 80 65 (81.3) 15 (18.8)
  Normal 286 228 (79.7) 58 (20.3)
 AST 0.029
  Abnormal 145 124 (85.5) 21 (14.5)
  Normal 218 166 (76.1) 52 (23.9)
 ALP 0.140
  Abnormal 135 113 (83.7) 22 (16.3)
  Normal 224 173 (77.2) 51 (22.8)
Kidney function
 BCr 0.756
  Abnormal 43 35 (81.4) 8 (18.6)
  Normal 322 257 (79.8) 65 (20.2)
 BUN 0.069
  Abnormal 45 41 (91.1) 4 (8.9)
  Normal 317 248 (78.2) 69 (21.8)
Tumor markers
 AFP 0.266
  Abnormal 179 146 (81.6) 33 (18.4)
  Normal 172 132 (76.7) 40 (23.3)
 CEA 0.176
  Abnormal 87 73 (83.9) 14 (16.1)
  Normal 248 191 (77.0) 57 (23.0)
 CA199 0.558
  Abnormal 103 83 (80.6) 20 (19.4)
  Normal 229 178 (77.7) 51 (22.3)

Data are presented as count with percentage in parentheses. Comparison between two groups was determined by chi-square test. A value of p < 0.05 was considered significant (bold).